GLP1-RAs and their place in the new T2D treatment algorithm
The position of GLP1RA agents in current Australian diabetes treatment algorithms requires GPs to re-think traditional models, including the role of these agents in combination with metformin or as an adjunct to other established treatments.
Sign up for free and continue reading
Med CPD offers the widest range of courses and content, all accessible in one place. Click on the Sign up button and start looking after the health of your career.
MDBriefCase Group Inc.
Speakers
A/Prof Gary Kilov
Dr Marwan Obaid
Duration
2 H